Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8471067rdf:typepubmed:Citationlld:pubmed
pubmed-article:8471067lifeskim:mentionsumls-concept:C0521119lld:lifeskim
pubmed-article:8471067lifeskim:mentionsumls-concept:C0302583lld:lifeskim
pubmed-article:8471067lifeskim:mentionsumls-concept:C0022086lld:lifeskim
pubmed-article:8471067lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:8471067lifeskim:mentionsumls-concept:C0062496lld:lifeskim
pubmed-article:8471067pubmed:issue7lld:pubmed
pubmed-article:8471067pubmed:dateCreated1993-5-10lld:pubmed
pubmed-article:8471067pubmed:abstractTextExtracellular iron is necessary for many biochemical reactions involved in Plasmodium falciparum growth and multiplication. The incorporation of radioactive iron taken up by the parasite was found, electrophoretically and via gamma counting, to be mainly associated with the haemozoin only in the presence of the active metabolism of the parasite. The potent antimalarial activity of desferrioxamine, a ferric iron chelating agent, has shown that iron deprivation is inhibitory to the parasite. We propose that the mechanism of action of desferrioxamine in addition to the chelation of iron from the parasitic compartment, chelates iron from the haemozoin crystal resulting in free radical generation and parasite death. The ability of desferrioxamine and not the ferrous iron chelating agent, 2,2'-bipyridyl, to chelate the non-haem iron from the haemozoin structure indicates that the oxidative state of iron associated with the haemozoin structure is ferric in nature.lld:pubmed
pubmed-article:8471067pubmed:languageenglld:pubmed
pubmed-article:8471067pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471067pubmed:citationSubsetIMlld:pubmed
pubmed-article:8471067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471067pubmed:statusMEDLINElld:pubmed
pubmed-article:8471067pubmed:monthAprlld:pubmed
pubmed-article:8471067pubmed:issn0006-2952lld:pubmed
pubmed-article:8471067pubmed:authorpubmed-author:MacPhailA PAPlld:pubmed
pubmed-article:8471067pubmed:authorpubmed-author:McNamaraLLlld:pubmed
pubmed-article:8471067pubmed:authorpubmed-author:HempelmannEElld:pubmed
pubmed-article:8471067pubmed:authorpubmed-author:HavlikIIlld:pubmed
pubmed-article:8471067pubmed:authorpubmed-author:van ZylR LRLlld:pubmed
pubmed-article:8471067pubmed:issnTypePrintlld:pubmed
pubmed-article:8471067pubmed:day6lld:pubmed
pubmed-article:8471067pubmed:volume45lld:pubmed
pubmed-article:8471067pubmed:ownerNLMlld:pubmed
pubmed-article:8471067pubmed:authorsCompleteYlld:pubmed
pubmed-article:8471067pubmed:pagination1431-6lld:pubmed
pubmed-article:8471067pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8471067pubmed:meshHeadingpubmed-meshheading:8471067-...lld:pubmed
pubmed-article:8471067pubmed:meshHeadingpubmed-meshheading:8471067-...lld:pubmed
pubmed-article:8471067pubmed:meshHeadingpubmed-meshheading:8471067-...lld:pubmed
pubmed-article:8471067pubmed:meshHeadingpubmed-meshheading:8471067-...lld:pubmed
pubmed-article:8471067pubmed:meshHeadingpubmed-meshheading:8471067-...lld:pubmed
pubmed-article:8471067pubmed:meshHeadingpubmed-meshheading:8471067-...lld:pubmed
pubmed-article:8471067pubmed:meshHeadingpubmed-meshheading:8471067-...lld:pubmed
pubmed-article:8471067pubmed:meshHeadingpubmed-meshheading:8471067-...lld:pubmed
pubmed-article:8471067pubmed:meshHeadingpubmed-meshheading:8471067-...lld:pubmed
pubmed-article:8471067pubmed:meshHeadingpubmed-meshheading:8471067-...lld:pubmed
pubmed-article:8471067pubmed:meshHeadingpubmed-meshheading:8471067-...lld:pubmed
pubmed-article:8471067pubmed:year1993lld:pubmed
pubmed-article:8471067pubmed:articleTitleMalaria pigment and extracellular iron. Possible target for iron chelating agents.lld:pubmed
pubmed-article:8471067pubmed:affiliationDepartment of Experimental and Clinical Pharmacology, University of the Witwatersrand, Medical School, Johannesburg, South Africa.lld:pubmed
pubmed-article:8471067pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8471067pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8471067pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed